CHL1 and Alzheimer disease: They demonstrated that Aβ42/40 (AUC = 0.973) and miR-384 (AUC = 0.909) in NDEVs co-labeled with neural cell adhesion molecule (NCAM) and ATP-binding cassette transporter A1 have potential advantages in AD diagnosis [178].